About this episode
欢迎收听最新一期的医学播客！在今天的节目中，我们将探讨一种名为Ofatumumab的新型免疫疗法。这项前瞻性、多中心队列研究显示，Ofatumumab在治疗难治性抗NMDA受体自身免疫脑炎（NMDAR-AE）方面显示出显著的疗效和安全性。研究发现，93.1%的患者在接受Ofatumumab治疗后，功能性结果得到了显著改善，且91.4%的患者达到了良好的功能预后。特别值得注意的是，对于一线免疫治疗失败的患者，Ofatumumab能更快地改善症状，并更频繁地达到良好的功能预后。这项研究为NMDAR-AE的管理提供了新的治疗选择。想了解更多细节吗？请继续关注我们的节目！
Get every episode summarized
Each time 萌喵读文献-神经病学 publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
